Related references
Note: Only part of the references are listed.PG-TIME: A practical approach to the clinical management of pyoderma gangrenosum
Agata Janowska et al.
DERMATOLOGIC THERAPY (2020)
Bone lesions in hairy cell leukemia: Diagnosis and treatment
Pawel Robak et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2020)
Clinical features and treatments of transient acantholytic dermatosis (Grover's disease): a systematic review
Francesco Bellinato et al.
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT (2020)
Prospective long-term follow-up after first-line subcutaneous cladribine in hairy cell leukemia: a SAKK trial
Rudolf Benz et al.
BLOOD ADVANCES (2020)
Hairy cell leukemia presenting with Ecthyma Gangrenosum- a case report
R. Sluga et al.
BMC INFECTIOUS DISEASES (2019)
Second primary cancers in patients with acute lymphoblastic, chronic lymphocytic and hairy cell leukaemia
Guoqiao Zheng et al.
BRITISH JOURNAL OF HAEMATOLOGY (2019)
Pyoderma gangrenosum - a guide to diagnosis and management
Christina George et al.
CLINICAL MEDICINE (2019)
A rash in a hairy situation: Leukocytoclastic vasculitis at presentation of hairy cell Leukemia
Justin T. Moyers et al.
AMERICAN JOURNAL OF HEMATOLOGY (2019)
THE BRAF INHIBITOR VEMURAFENIB PLUS RITUXIMAB PRODUCES A HIGH RATE OF DEEP AND DURABLE RESPONSES IN RELAPSED/REFRACTORY HAIRY CELL LEUKEMIA: UPDATED RESULTS OF A PHASE-2 TRIAL
E. Tiacci et al.
HEMATOLOGICAL ONCOLOGY (2019)
Severe polymorphic erythema due to interferon α-2b during treatment of hairy cell leukemia
Chen Li et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2019)
High prevalence of antibiotic allergies in cladribine-treated patients with hairy cell leukemia - lessons for immunopathogenesis and prescribing
Zaal Meher-Homji et al.
LEUKEMIA & LYMPHOMA (2019)
Outcomes and second neoplasms in hairy cell leukemia: A retrospective cohort
Wellington F. da Silva et al.
LEUKEMIA RESEARCH (2019)
Targeting MEK in vemurafenib-resistant hairy cell leukemia
Rebecca Caeser et al.
LEUKEMIA (2019)
Secondary malignancies after treatment with single-agent vemurafenib in two patients with refractory hairy cell leukemia
Munveer S. Bhangoo et al.
LEUKEMIA & LYMPHOMA (2019)
Insights Into the Pathogenesis of Sweet's Syndrome
Michael S. Heath et al.
FRONTIERS IN IMMUNOLOGY (2019)
Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia
Robert J. Kreitman et al.
LEUKEMIA (2018)
Treatment with Combination of Dabrafenib and Trametinib in Patients with Recurrent/Refractory BRAF V600E-Mutated Hairy Cell Leukemia (HCL)
Robert J. Kreitman et al.
BLOOD (2018)
Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia
Michael R. Grever et al.
BLOOD (2017)
Bullous Pyoderma Gangrenosum Associated with Hairy Cell Leukemia and Its Complete Response to Cladribine Therapy
Ankur Jain et al.
INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION (2017)
Bullous Pyoderma Gangrenosum Associated with Hairy Cell Leukemia and Its Complete Response to Cladribine Therapy
Ankur Jain et al.
INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION (2017)
Concomitant B Hairy Cell Leukemia and Mycosis Fungoides in an Elderly Man
Eric Wong et al.
CASE REPORTS IN DERMATOLOGY (2017)
Purpuric exanthema in a patient with hairy cell leukemia treated with cladribine and allopurinol
Pablo Espinosa Lara et al.
ANNALS OF HEMATOLOGY (2017)
Long-term durable remission by cladribine followed by rituximab in patients with hairy cell leukaemia: update of a phase II trial
Dai Chihara et al.
BRITISH JOURNAL OF HAEMATOLOGY (2016)
2016 US Lymphoid Malignancy Statistics by World Health Organization Subtypes
Lauren R. Teras et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Leukocytoclastic vasculitis associated with hairy cell leukemia at diagnosis: a case report and review of the literature
Alessandro Broccoli et al.
TUMORI (2016)
Leukocytoclastic vasculitis associated with hairy cell leukemia at diagnosis: a case report and review of the literature
Alessandro Broccoli et al.
TUMORI (2016)
Hairy cell leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upaEuro
T. Robak et al.
ANNALS OF ONCOLOGY (2015)
Melanoma and non-melanoma skin cancers in hairy cell leukaemia: a Surveillance, Epidemiology and End Results population analysis and the 30-year experience at Memorial Sloan Kettering Cancer Center
Justin M. Watts et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
Potential breakthroughs with investigational drugs for hairy cell leukemia
Tadeusz Robak et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2015)
Targeting Mutant BRAF in Relapsed or Refractory Hairy-Cell Leukemia
E. Tiacci et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Cutaneous Toxic Effects of BRAF Inhibitors Alone and in Combination With MEK Inhibitors forMetastatic Melanoma
Giuliana Carlos et al.
JAMA DERMATOLOGY (2015)
Complete recovery of pyoderma gangrenosum after successful treatment of underlying hairy cell leukemia with cladribine
Anil Tombak et al.
KOREAN JOURNAL OF INTERNAL MEDICINE (2015)
Rituximab therapy for hairy cell leukemia: a retrospective study of 41 cases
Mathieu Leclerc et al.
ANNALS OF HEMATOLOGY (2015)
Rapid and complete hematological response of refractory hairy cell leukemia to the BRAF inhibitor dabrafenib
V. Vergote et al.
ANNALS OF HEMATOLOGY (2014)
Hairy cell leukemia presenting initially with symptoms of Behcet's disease
Mustafa Ferhat Oksuz et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2014)
Disseminated ulcerating lupus panniculitis emerging under interferon therapy of hairy cell leukemia: Treatment- or disease-related?
Mirjana Urosevic-Maiwald et al.
JOURNAL OF DERMATOLOGY (2014)
IgA vasculitis revealing hairy cell leukemia relapse treated by cladribine
Alexandra Audemard et al.
PRESSE MEDICALE (2014)
A Case Report of Hairy Cell Leukemia Presenting Concomitantly with Sweet Syndrome
Mohammad Alkayem et al.
CASE REPORTS IN MEDICINE (2014)
2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides
J. C. Jennette et al.
ARTHRITIS AND RHEUMATISM (2013)
Improved survival in hairy cell leukaemia over three decades: a SEER database analysis of prognostic factors
Rekha Chandran et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
Analysis of Dermatologic Events in Vemurafenib-Treated Patients With Melanoma
Mario E. Lacouture et al.
ONCOLOGIST (2013)
RAS Mutations Are Associated With the Development of Cutaneous Squamous Cell Tumors in Patients Treated With RAF Inhibitors
Patrick A. Oberholzer et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Atypical Melanocytic Proliferations and New Primary Melanomas in Patients With Advanced Melanoma Undergoing Selective BRAF Inhibition
Lisa Zimmer et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
High incidence of skin rash in patients with hairy cell leukemia treated with cladribine
Chezi Ganzel et al.
LEUKEMIA & LYMPHOMA (2012)
Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 Mutations
Keith T. Flaherty et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
RAS Mutations in Cutaneous Squamous-Cell Carcinomas in Patients Treated with BRAF Inhibitors
Fei Su et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Hairy Cell Leukemia and cutaneous involvement
Ulku Ergene et al.
TRANSFUSION AND APHERESIS SCIENCE (2012)
RAF inhibition and induction of cutaneous squamous cell carcinoma
Caroline Robert et al.
CURRENT OPINION IN ONCOLOGY (2011)
Vasculitis in A Patient with Hairy Cell Leukemia
Abdullah Ozkok et al.
INTERNAL MEDICINE (2011)
Long-term results for pentostatin and cladribine treatment of hairy cell leukemia
Claire E. Dearden et al.
LEUKEMIA & LYMPHOMA (2011)
Historical treatments of in hairy cell leukemia, splenectomy and interferon: past and current uses
Thomas M. Habermann et al.
LEUKEMIA & LYMPHOMA (2011)
Unusual clinical manifestations, rare sites of involvement, and the association of other disorders with hairy cell leukemia
Tamar Tadmor et al.
LEUKEMIA & LYMPHOMA (2011)
Nontuberculous mycobacterium genital infection mimicking donovanosis in a patient with hairy cell leukemia
Romulo Jose de Lucena Castro Filho et al.
LEUKEMIA RESEARCH (2011)
Very long-term eradication of minimal residual disease in patients with hairy cell leukemia after a single course of cladribine
Darren S. Sigal et al.
BLOOD (2010)
Specific skin lesions in hairy cell leukemia at presentation: case report and review of literature
N. Colovic et al.
MEDICAL ONCOLOGY (2010)
Long-term follow-up of 233 patients with hairy cell leukaemia, treated initially with pentostatin or cladribine, at a median of 16 years from diagnosis
Monica Else et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Leukemia cutis
Jeong Hee Cho-Vega et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2008)
Hairy cell leukemia: Current concepts
Timothy Cannon et al.
CANCER INVESTIGATION (2008)
ECTHYMA GANGRENOSUM IN A NON-NEUTROPAENIC, ELDERLY PATIENT: CASE REPORT AND REVIEW OF THE LITERATURE
S. Bettens et al.
ACTA CLINICA BELGICA (2008)
Vasculitides associated with malignancies:: Analysis of sixty patients
Olivier Fain et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2007)
Polyarteritis nodosa in hairy cell leukaemia: an autopsy report
Mahesha Vankalakunti et al.
JOURNAL OF CLINICAL PATHOLOGY (2007)
High frequency of primary cutaneous lymphomas associated with lymphoproliferative disorders of different lineage
Christian Hallermann et al.
ANNALS OF HEMATOLOGY (2007)
Acute vasculitis as a first manifestation of hairy cell leukemia
Anna Remkova et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2007)
Second cancer incidence and cause-specific mortality among 3104 patients with hairy cell leukemia: A population-based study
Michie Hisada et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Skin lesions in chronic lymphocytic leukemia
Ewa Robak et al.
LEUKEMIA & LYMPHOMA (2007)
Mycosis fungoides associated with B-cell malignancies
A. Barzilai et al.
BRITISH JOURNAL OF DERMATOLOGY (2006)
Cutaneous reactions in hairy cell leukaemia treated with 2-chlorodeoxyadenosine and allopurinol
Y Chubar et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Phase 2 study of rituximab in the treatment of cladribine-failed patients with hairy cell leukemia
J Nieva et al.
BLOOD (2003)
Rituximab in relapsed or refractory hairy cell leukemia
DA Thomas et al.
BLOOD (2003)
Sweet syndrome as the presenting symptom of relapsed hairy cell leukemia
RM Levy et al.
ARCHIVES OF DERMATOLOGY (2002)
Systemic vasculitis complicating hairy cell leukaemia treatment with cladribine
B Tousi et al.
CLINICAL AND LABORATORY HAEMATOLOGY (2002)
Severe skin rash in two consecutive patients treated with 2-chlorodeoxyadenosine for hairy cell leukaemia at a single institution
MR Grey et al.
CLINICAL AND LABORATORY HAEMATOLOGY (2000)
Acute necrotising vasculitis in hairy cell leukemia - rapid response to cladribine: case report and a brief review of the literature
P Seshadri et al.
LEUKEMIA RESEARCH (2000)
Share Paper
